Endothelial Derived Vasorelaxation Is Impaired in Human APO A-I Transgenic Rabbits
- 8 December 1997
- journal article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 241 (1), 205-211
- https://doi.org/10.1006/bbrc.1997.7790
Abstract
No abstract availableKeywords
This publication has 36 references indexed in Scilit:
- Inhibition of Atherosclerosis Development in Cholesterol-Fed Human Apolipoprotein A-I–Transgenic RabbitsCirculation, 1996
- Supplementation of hypercholesterolaemic rabbits with L-arginine reduces the vascular release of superoxide anions and restores NO productionAtherosclerosis, 1995
- Dietary arginine prevents atherogenesis in the coronary artery of the hypercholesterolemic rabbitJournal of the American College of Cardiology, 1994
- Impairment of endothelium-dependent dilation is an early event in children with familial hypercholesterolemia and is related to the lipoprotein(a) level.JCI Insight, 1994
- Impaired coronary blood flow response to acetylcholine in patients with coronary risk factors and proximal atherosclerotic lesions.JCI Insight, 1993
- Antiatherogenic effects of L-arginine in the hypercholesterolemic rabbit.JCI Insight, 1992
- Inhibition of early atherogenesis in transgenic mice by human apolipoprotein AINature, 1991
- Modulation of coronary vasomotor tone in humans. Progressive endothelial dysfunction with different early stages of coronary atherosclerosis.Circulation, 1991
- Impaired vasodilation of forearm resistance vessels in hypercholesterolemic humans.JCI Insight, 1990
- Vascular endothelial cells synthesize nitric oxide from L-arginineNature, 1988